• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

High neighborhood walkability linked with lower rates of obesity and diabetes

byAdarsh ManjunathandMichael Milligan
May 26, 2016
in Chronic Disease, Endocrinology, Public Health
Reading Time: 2 mins read
No significant improvement in older adult cognitive function with moderate physical activity
Share on FacebookShare on Twitter

1. Neighborhoods with the highest degree of walkability had the lowest rates of obesity and diabetes.

2. Rates of walking, cycling, and public transit use were significantly higher and car use was lowest in the most walkable neighborhoods.

Evidence Rating Level: 2 (Good)

Study Rundown: It is well known that rates of obesity and diabetes remain high despite public health efforts to improve diet and exercise. The neighborhood a person lives in can have a large influence on the amount of daily exercise a person performs. The purpose of this study was to determine whether more walkable neighborhoods were associated with a slower increase in rates of overweight, obesity, and diabetes. In a study of over 8700 Canadian neighborhoods that were ranked by their walkability, the prevalence of overweight and obesity was 10% lower in the neighborhoods ranked in the top quintile of walkability compared to those in the lowest quintile. The incidence of diabetes was similarly lower in the top quintile of walkability. Furthermore, rates of walking, cycling, and public transit use were significantly higher in the top quintile of walkability and the rate of car use lowest.

Overall, this study suggests that neighborhoods with higher levels of walkability were associated with decreased rates of overweight, obesity, and diabetes. The study benefited by analyzing a large array of neighborhoods, but all were located in Ontario, Canada, limiting generalizability. Additionally, there were certainly unaccounted variables, other than walkability, that would likely influence the outcomes, such as occupation.

Click to read the study in JAMA

RELATED REPORTS

Duodenal-jejunal bypass liners may improve glycemic control in patients with diabetes

Telehealth yields modest improvements in diabetes outcomes 

Tirzepatide improves blood sugar control in metformin-refractory type 2 diabetes

Relevant Reading: Physical activity in relation to urban environments in 14 cities worldwide: a cross-sectional study

In-Depth [prospective study]: This study assessed 8770 neighborhoods in Ontario, Canada and ranked each based on their walkability score. These neighborhoods were ranked and classified into quintiles, with quintile 5 defined as the most walkable areas. Rates of overweight, obesity, and diabetes were determined from the Canadian Community Health Survey. The prevalence of overweight and obesity in 2001 was lower in quintile 5 vs. quintile 1 (43.3% vs. 53.5%, p < 0.001). The adjusted diabetes incidence was also lowest in quintile 5 at 7.7/1000 persons in 2001 and decreased to 6.2/1000 persons in 2012 (absolute change -1.5; 95%CI -2.6 to -0.4). Furthermore, rates of walking, cycling, and public transit use were significantly higher in the top quintile of walkability and the rate of car use lowest.

 

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: diabetes mellitusexerciseobesitysocioeconomic status
Previous Post

High sodium consumption associated with cardiovascular disease in patients with chronic kidney disease

Next Post

Inhibitors more likely to develop against recombinant factor VIII than plasma-derived factor VIII: The SIPPET study

RelatedReports

Surgery

Duodenal-jejunal bypass liners may improve glycemic control in patients with diabetes

July 16, 2026
Chronic Disease

Telehealth yields modest improvements in diabetes outcomes 

June 22, 2026
Food environment associated with gestational diabetes
Chronic Disease

Tirzepatide improves blood sugar control in metformin-refractory type 2 diabetes

May 25, 2026
Chronic Disease

Exercise continues to outperform pharmacologic longevity strategies

May 20, 2026
Next Post
New genetic link in pulmonary arterial hypertension holds therapeutic promise

Inhibitors more likely to develop against recombinant factor VIII than plasma-derived factor VIII: The SIPPET study

Earlier puberty associated with increased risk of depression in girls

Earlier puberty associated with increased risk of depression in girls

Infertility treatments not associated with increased short-term cancer risk

Young cancer survivors may not understand impact of treatment on future fertility

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Prognostic associations of anthropometric indices vary by clinical outcomes
  • Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma
  • Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.